by Jordana Choucair | Jul 8, 2022 | Life Sciences
Beginning next year, pharmaceutical companies must repay Medicare for any injectable and infused drugs that come in single-dose vials and go unused, in a bid to cut down on the billions of dollars that are wasted every year on discarded drugs. Drug companies that...
by Jordana Choucair | Jul 8, 2022 | Payers
The Centers for Medicare & Medicaid Services (CMS) released its proposed 2023 Physician Fee Schedule rule, revealing a small decline in physician Medicare payments next year. CMS proposed a 2023 fee schedule conversion factor of $33.08 for each relative unit which...
by Jordana Choucair | Jul 8, 2022 | Payers
Mercer released findings from its Survey on Health and Benefit Strategies, indicating that employers will focus on affordability and access in designing health benefits for 2023. The report found that two-thirds of the 708 employers polled plan to enhance their health...
by Jordana Choucair | Jul 8, 2022 | Public Health/Prevention
A new Kaiser Family Foundation (KFF) analysis found that the U.S. has by far the highest child and teen firearm mortality rate compared to other industrialized nations. According to the analysis, firearms are now the number one cause of death for children in the U.S.,...
by Jordana Choucair | Jul 7, 2022 | Life Sciences
Senate Democrats narrowly reached a deal on drug pricing reforms, which includes granting Medicare the power to negotiate prices for certain drugs. According to text released Wednesday, the U.S. Department of Health and Human Services (HHS) will choose 10 drugs...
Recent Comments